TERGO XCF3

Hazard statements (CLP)

H302, H332, H335, H336, H412

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to

Contains

trans-1,2-DICHLOROETHYLENE; (Z)-1-chloro-2,3,3-trifluoropropene 0 % of components with unknown hazards to the aquatic environment

Signal word

Warning

Hazard statements

H302 - Harmful if swallowed H332 - Harmful if inhaled H412 - Harmful to aquatic life with long lasting effects H336 - May cause drowsiness or dizziness EUH210 - Safety data sheet available on request

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P264 - Wash face, hands and any exposed skin thoroughly after handling. P273 - Avoid release to the environment. P312 - Call a POISON CENTER or doctor if you feel unwell. P403 + P233 - Store in a well-ventilated place. Keep container tightly closed. P501 - Dispose of contents/ container to an approved waste disposal plant. Unknown acute toxicity 100 % of the mixture consists of ingredient(s) of unknown acute toxicity. 15 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 30 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). Unknown aquatic toxicity

Additional information

This product requires tactile warnings if supplied to the general public.

Other hazards

No information available.

PBT Substances

& vPvB None known. This product does not contain any known or suspected endocrine disruptors. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors.

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity - Oral Category 4 - (H302) Acute toxicity - Inhalation (Dusts/Mists) Category 4 - (H332) Specific target organ toxicity — single exposure Category 3 - (H335, H336) Chronic aquatic toxicity Category 3 - (H412)